Category: Drugs

Anesthesia Drug Shortages Continue.

Since the great propofol shortage of 2010-11 there have been intermittent shortages of many drugs in many classes.  Chemotherapeutics, antihypertensives, you name it, its been short.  This is a blog about all things anesthesia so naturally we have taken that angle.  With that in mind I will again post the generic form you can cut and paste and send to your favorite generic drug maker:

Dear Generic Drug Maker,

It is both annoying and possibly life-threatening that we no longer have adequate supplies of _______.  Please make more, thanks.

Signed,

“Anesthesia”

 

Not really sure how to deal with this problem (besides poking fun at it) we, at The Anesthesia Blog, have compiled a list of useful links.  The ASA is also taking a stand and getting behind the “Preserving Access to Life-Saving Medications Act” which would at least let give the FDA some lead time in dealing with an impending shortage.

Useful resources:

Image: vongvanvi / FreeDigitalPhotos.net

 

Journal Watch: Local Anesthestic Toxicity and Lipid Rescue

The toxicity of local anesthetics makes many a sphincter clench, especially for those of us who routinely practice regional anesthesia.  The advent of lipid rescue by Dr Weinberg and colleagues, has been a tremendous advance in the safety of regional anesthesia.  Dr Weinberg has established the excellent registry of cases over at Lipid Rescue.org

The advances keep a-happenin as they say.  It is a relatively new area of study one not amenable to randomized controlled trials in humans…hard to tell the IRB that the control group gets sugar water after a mega-dose of bupivicaine.   Therefore, most new data comes from our friends at the bench.  This months Anesthesiology further adds to our knowledge base on this topic.  Researchers in the U.K. analyzed the difference between mixed (medium- and long-chain) and long-chain lipid emulsions, for their ability to extract local anesthetic from serum.  They concluded that the type of emulsion may make the reversal more effective:

Lipofundin®, a lipid emulsion containing 50% each of medium-and long-chain triglycerides, sequestered all three drugs to a significantly greater extent than Intralipid® (long-chain triglycerides only) from human serum, which is in contrast with previous studies describing extraction from a buffer solution. These findings call into question the current advanced cardiac life support guidelines specifying use of a long-chain triglyceride emulsion for lipid rescue,23 although further in vivo studies that confirm a significant improvement in resuscitation from local anesthetic toxicity with Lipofundin® are obviously required before drawing any confident conclusions.

In case you ended up here at this post in an emergency, or just want a refresher the protocol is as follows (from lipidrescue.org):

20% Intralipid:

  1. Administer 1.5 mL/kg as an initial bolus; the bolus can be repeated 1- 2 times for persistent asystole.
  2. Start an infusion at 0.25 mL/kg/min for 30-60 minutes; increase infusion rate up to 0.50 mL/kg/min for refractory hypotension.

or you can print it out here.  ASRA pdf version of protocol here.

Update 1/31/12.

Thanks to Dr Patel for bringing the “Lipid ALS” app to my attention.  We may get around to a full review but from the screenshots its seems worth the price:


Image: digitalart / FreeDigitalPhotos.net

 

 

R.I.P. Sodium Thiopental

2010 may indeed be the year of the anesthesia drug shortage.  Propofol, Rocuronium, Sux, Neostigmine…the list goes on.  We’ve had to manage with other drugs, less of this, more of that type of anesthesia.  Not the optimal care we all strive to provide on a day to say basis.  Sodium thiopental is the latest shortage to hit a Pyxis near you.  Since the last time I used it was during a Neuro induction in residency with a dinosaur attending…I won’t miss it.  The advantages of the milky stuff seem to far outweigh any advantage over “truth serum”.  

This has been an interesting debate to follow however with countries drawing lines in the sand based on their stance on capital punishment.  Note to executioner: Propofol does the same thing…and the shortage is over (for now).
From the NY Times

A combination of market forces and European objections to the death penalty have left the nation’s busiest execution chamber with only enough of a key drug — sodium thiopental — to use for two convicted murderers scheduled to die later this month.

IV Acetaminophen approved.

Like many a drug, IV acetaminophen has been available outside of the United States for quite some time now.   The IV formulation of the “painkiller hospitals use most” has a proven track record of safety and efficacy and should have been available some time ago IMHO.  The opiod-sparing effects are of the most interest to us as anesthesia providers.  The drug-naming focus group really dropped the ball on this one though.  Ofirmev? Hurts my tongue to say it.  Doesn’t lessen my excitement to use it though.  Now just to get it on formulary.  My sources are saying around $12 per 1000 mg dose.

Package Insert

No more glass bottles of NTG?

A new drug has been approved for intravenous therapy of hypertension…Cleviprex (clevidipine butyrate injectable emulsion).
From The Medicines Company’s press release.
The Medicines Company (NASDAQ: MDCO) announced today that the U.S.Food and Drug Administration (FDA) has approved the intravenous (IV)therapy Cleviprex(TM) (clevidipine butyrate) injectable emulsion forthe reduction of blood pressure when oral therapy is not feasible or not desirable. Cleviprex, a
novel IV antihypertensive, represents an advancement over currently available
therapies, providing rapid and precise control of blood pressure in the critical
care setting. Backed by comprehensive data in the emergency department, operating room and intensive care unit, Cleviprex offers physicians an important
new therapeutic option for the management of blood pressure.

It appears more suited for the ED setting where a prolonged infusion might be required in the setting of malignant hypertension. Not quite sure this drug would have any significant advantage over NTG of Nitroprusside in the operating room. Any experiences? Please share.